These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32247227)

  • 21. Dose prediction with deep learning for prostate cancer radiation therapy: Model adaptation to different treatment planning practices.
    Kandalan RN; Nguyen D; Rezaeian NH; Barragán-Montero AM; Breedveld S; Namuduri K; Jiang S; Lin MH
    Radiother Oncol; 2020 Dec; 153():228-235. PubMed ID: 33098927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Error detection using a convolutional neural network with dose difference maps in patient-specific quality assurance for volumetric modulated arc therapy.
    Kimura Y; Kadoya N; Tomori S; Oku Y; Jingu K
    Phys Med; 2020 May; 73():57-64. PubMed ID: 32330812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Feasibility of MRI-only treatment planning for proton therapy in brain and prostate cancers: Dose calculation accuracy in substitute CT images.
    Koivula L; Wee L; Korhonen J
    Med Phys; 2016 Aug; 43(8):4634. PubMed ID: 27487880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dosimetric and radiobiological comparison of prostate VMAT plans optimized using the photon and progressive resolution algorithm.
    Chow JCL; Jiang R; Xu L
    Med Dosim; 2020 Spring; 45(1):14-18. PubMed ID: 31103251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deep DoseNet: a deep neural network for accurate dosimetric transformation between different spatial resolutions and/or different dose calculation algorithms for precision radiation therapy.
    Dong P; Xing L
    Phys Med Biol; 2020 Feb; 65(3):035010. PubMed ID: 31869825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose impact of rectal gas on prostatic IMRT and VMAT.
    Sasaki M; Ikushima H; Tominaga M; Kamomae T; Kishi T; Oita M; Harada M
    Jpn J Radiol; 2015 Dec; 33(12):723-33. PubMed ID: 26573828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bladder dose accumulation based on a biomechanical deformable image registration algorithm in volumetric modulated arc therapy for prostate cancer.
    Andersen ES; Muren LP; Sørensen TS; Noe KO; Thor M; Petersen JB; Høyer M; Bentzen L; Tanderup K
    Phys Med Biol; 2012 Nov; 57(21):7089-100. PubMed ID: 23051686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. VMAT vs. 7-field-IMRT: assessing the dosimetric parameters of prostate cancer treatment with a 292-patient sample.
    Kopp RW; Duff M; Catalfamo F; Shah D; Rajecki M; Ahmad K
    Med Dosim; 2011; 36(4):365-72. PubMed ID: 21377863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient-specific three-dimensional dose distribution prediction via deep learning for prostate cancer therapy: Improvement with the structure loss.
    Koike Y; Takegawa H; Anetai Y; Ohira S; Nakamura S; Tanigawa N
    Phys Med; 2023 Mar; 107():102544. PubMed ID: 36774846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The dosimetric effects of photon energy on the quality of prostate volumetric modulated arc therapy.
    Mattes MD; Tai C; Lee A; Ashamalla H; Ikoro NC
    Pract Radiat Oncol; 2014; 4(1):e39-44. PubMed ID: 24621430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Knowledge-based prediction of three-dimensional dose distributions for external beam radiotherapy.
    Shiraishi S; Moore KL
    Med Phys; 2016 Jan; 43(1):378. PubMed ID: 26745931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Three-dimensional dose prediction for lung IMRT patients with deep neural networks: robust learning from heterogeneous beam configurations.
    Barragán-Montero AM; Nguyen D; Lu W; Lin MH; Norouzi-Kandalan R; Geets X; Sterpin E; Jiang S
    Med Phys; 2019 Aug; 46(8):3679-3691. PubMed ID: 31102554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of volumetric-modulated arc therapy and intensity-modulated radiation therapy prostate cancer plans accounting for cold spots.
    Nguyen TTT; Arimura H; Asamura R; Hirose TA; Ohga S; Fukunaga JI
    Radiol Phys Technol; 2019 Jun; 12(2):137-148. PubMed ID: 30805779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of bladder contrast on dose calculation in volumetric modulated arc therapy planning in patients treated for postoperative prostate cancer.
    Ercan T; İğdem Ş; Alço G
    Jpn J Radiol; 2016 May; 34(5):376-82. PubMed ID: 26842552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MR-based treatment planning in radiation therapy using a deep learning approach.
    Liu F; Yadav P; Baschnagel AM; McMillan AB
    J Appl Clin Med Phys; 2019 Mar; 20(3):105-114. PubMed ID: 30861275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment planning for radiotherapy with very high-energy electron beams and comparison of VHEE and VMAT plans.
    Bazalova-Carter M; Qu B; Palma B; Hårdemark B; Hynning E; Jensen C; Maxim PG; Loo BW
    Med Phys; 2015 May; 42(5):2615-25. PubMed ID: 25979053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A feasibility study of automated inverse treatment planning for cancer of the prostate.
    Reinstein LE; Wang XH; Burman CM; Chen Z; Mohan R; Kutcher G; Leibel SA; Fuks Z
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):207-14. PubMed ID: 9422578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Applying a commercial atlas-based synthetic Computed Tomography algorithm to patients with hip prostheses for prostate Magnetic Resonance-only radiotherapy.
    Wyatt J; McCallum H
    Radiother Oncol; 2019 Apr; 133():100-105. PubMed ID: 30935564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fully automated dose prediction using generative adversarial networks in prostate cancer patients.
    Murakami Y; Magome T; Matsumoto K; Sato T; Yoshioka Y; Oguchi M
    PLoS One; 2020; 15(5):e0232697. PubMed ID: 32365088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of testicular dose delivered by intensity-modulated radiation therapy (IMRT) and volumetric-modulated arc therapy (VMAT) in patients with prostate cancer.
    Martin JM; Handorf EA; Price RA; Cherian G; Buyyounouski MK; Chen DY; Kutikov A; Johnson ME; Ma CM; Horwitz EM
    Med Dosim; 2015; 40(3):186-9. PubMed ID: 25595491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.